Stacey Bilinski
Directeur Technique/Scientifique/R&D chez IN8BIO, INC.
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| William Ho | M | 48 | 8 ans | |
| Patrick McCall | M | 41 | 3 ans | |
| Peter Brandt | M | 67 | 5 ans | |
| Alan Roemer | M | 54 | 4 ans | |
| Emily Fairbairn | F | 62 | 3 ans | |
| Travis Whitfill | M | 34 | 6 ans | |
| Luba Greenwood | F | 45 | 3 ans | |
| Lawrence Lamb | M | 70 | 8 ans | |
| Kate Rochlin | M | 43 | 4 ans | |
| Corinne Epperly | M | 46 | 1 ans | |
| Jeremy Graff | M | - | 1 ans | |
| Trishna Goswami | M | 46 | 3 ans | |
| Urvashi Patel | M | - | 2 ans | |
| Kenneth R. LaMontagne | M | - | 2 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Vojislav Vukovic | M | 57 |
Taiho Oncology, Inc.
 Taiho Oncology, Inc. Pharmaceuticals: MajorHealth Technology Taiho Oncology, Inc. develops and markets anti-metabolite cancer drugs. It focuses on cornerstone anti-metabolites as well as on targeted small molecule inhibitors. The firm engages in the research, development, and manufacturing of pharmaceutical products in the fields of oncology, allergy and immunology, and urology. It also offers nutrient tonic and crude drug gastrointestinal remedy products. The company was founded in 2002 and is headquartered in Princeton, NJ. | 1 ans |
| Susan Romanus | F | 58 |
Taiho Oncology, Inc.
Taiho Oncology, Inc. Pharmaceuticals: MajorHealth Technology Taiho Oncology, Inc. develops and markets anti-metabolite cancer drugs. It focuses on cornerstone anti-metabolites as well as on targeted small molecule inhibitors. The firm engages in the research, development, and manufacturing of pharmaceutical products in the fields of oncology, allergy and immunology, and urology. It also offers nutrient tonic and crude drug gastrointestinal remedy products. The company was founded in 2002 and is headquartered in Princeton, NJ. | 3 ans |
| Robert Chen | M | - |
Taiho Oncology, Inc.
Taiho Oncology, Inc. Pharmaceuticals: MajorHealth Technology Taiho Oncology, Inc. develops and markets anti-metabolite cancer drugs. It focuses on cornerstone anti-metabolites as well as on targeted small molecule inhibitors. The firm engages in the research, development, and manufacturing of pharmaceutical products in the fields of oncology, allergy and immunology, and urology. It also offers nutrient tonic and crude drug gastrointestinal remedy products. The company was founded in 2002 and is headquartered in Princeton, NJ. | 1 ans |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Etats-Unis | 17 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Stacey Bilinski
- Réseau Personnel
